Founded in 2022 by Population Health Partners and ARCH Venture Partners, the biotech venture giant led by Bob Nelsen, Metsera ...

The specialty grocer, which spends millions each year on insulin for employees, accused the companies of profiting from ...

IQ+, our most advanced algorithm ever, together with the benefits of Abbott's latest CGM sensor on our tested and trusted ...

An Italian study shows that using GLP-1 receptor agonists can lead to remission in up to 18% of cases, especially when used ...

MK-677 (also known as ibutamoren or MK-0677) is an orally active ghrelin receptor (GHSR-1a) agonist that increases pul ...

Gov. Gavin Newsom’s CalRx program will sell five-packs of insulin pens for $55 starting in January, a landmark step toward ...

Type 1 diabetes (T1D) is a chronic autoimmune disease that results from the destruction of insulin-producing β-cells in the ...

Thank you, operator, and welcome to DexCom's Third Quarter 2025 Earnings Call. Our agenda begins with Jake Leach, DexCom's President and Interim CEO, who will summarize our recent highlights and ...

With Deepavali just around the corner, aren’t we all buzzing with excitement? Homes twinkling with diyas, family gatherings, ...

Walmart will offer in‑store pickup of Eli Lilly’s discounted weight‑loss drug Zepbound, giving self‑pay customers easier, ...

Civica will begin selling a type of insulin on Jan. 1, 2026, although it will not come from the nonprofit drug maker’s ...

Discover how adopting a low-fat vegan diet for type 1 diabetes may reduce insulin use and help manage costs effectively.